Abraxis Oncology
 
Bookmark Send to a Colleague

Medical Affairs

Home > Medical Affairs > Treatment Guidelines

Treatment Guidelines

National Cancer Institute PDQ Cancer Information Summaries

PDQ (Physician Data Query) is NCI's comprehensive cancer database containing peer-reviewed PDQ cancer information summaries on cancer treatment, screening, prevention, genetics, and supportive care, and are updated monthly by 6 editorial boards.

Access the NCI PDQ Cancer Information Summaries.

NCCN Clinical Practice Guidelines

The National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology™ are the recognized standard for clinical policy in the oncology community. These guidelines are updated at least annually in a consensus-driven process with explicit review of the evidence by multidisciplinary panels of expert physicians from NCCN Member Institutions.

Access the NCCN Clinical Practice Guidelines in Oncology.

Compliance Declaration Investor Relations Site Map Terms of Use Privacy Policy Glossary Comprehensive Bibliography

Abraxis Oncology is a division of Abraxis BioScience, LLC. AO 997/268353 August 2008
All Abraxis BioScience, LLC corporate names (eg, ABRAXIS, ABRAXIS ONCOLOGY, ABRAXIS BIOSCIENCE, and their logos), names of services, and names of products (eg, ABRAXANE® and the ABRAXANE logo) referred to herein are trade names, service marks and/or trademarks that are owned by or licensed to Abraxis BioScience, its divisions, or its affiliates, unless otherwise noted.